This inventor holds 1 USPTO granted patent. Top assignees: Rhone Poulenc Rorer, The University of Texas System. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 38 
1 out of 5,644 
Years Active: 1997
Title: Wei Wei Zhang: Innovator in Gene Therapy Quality Control
Introduction
Wei Wei Zhang is a notable inventor based in Grayslake, Illinois. He has made significant contributions to the field of gene therapy, particularly in quality control for recombinant agents. His work focuses on ensuring the efficacy of gene therapy treatments, which can have profound implications for medical science.
Latest Patents
Wei Wei Zhang holds a patent for a "Rapid test for determining the amount of functionally inactive gene." This invention is crucial for quality control in gene therapy, as it provides an assay to identify the percentage of defective or therapeutically inactive vectors in a vector stock. This innovation enhances the reliability of gene therapy applications.
Career Highlights
Throughout his career, Wei Wei Zhang has worked with prominent organizations, including Rhone Poulenc Rorer and the University of Texas System. His experience in these institutions has allowed him to develop and refine his expertise in gene therapy and related technologies.
Collaborations
Wei Wei Zhang has collaborated with notable professionals in his field, including Bruno Tocque and Laurent Bracco. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Wei Wei Zhang's contributions to gene therapy quality control exemplify the importance of innovation in medical science. His patent and collaborations reflect a commitment to improving therapeutic outcomes for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile